Previous Close | 63.59 |
Open | 62.88 |
Bid | 62.64 x N/A |
Ask | 63.24 x N/A |
Day's Range | 62.88 - 62.88 |
52 Week Range | 58.96 - 73.25 |
Volume | |
Avg. Volume | 0 |
Market Cap | N/A |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | Jul 31, 2024 - Aug 05, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Cognizant (CTSH) introduces Neuro Edge. The suite empowers businesses with real-time, secure AI at the edge for faster decisions and operational efficiency across industries.
Cognizant (NASDAQ: CTSH) announced the launch of Cognizant Neuro®️ Edge, a new platform in the Cognizant Neuro®️ suite, designed to empower businesses across industries to leverage artificial intelligence and generative AI at the edge.
With its stock down 5.2% over the past three months, it is easy to disregard Cognizant Technology Solutions...